DATASEA INC. (DTSS) - 10-Q Filing Summary
Business Context and Reporting Period
Company: DATASEA INC.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Six months ended December 31, 2025 (Fiscal Q2 2026)
Business Overview: Datasea operates two primary segments: Acoustic High-Tech (ultrasound, infrasound, AI-driven health/industrial applications) and 5G+AI Multimodal Digitalization (AI-driven digital services, new media marketing, and smart city solutions). The company is a Nevada corporation with operations primarily in the People's Republic of China (PRC) through Variable Interest Entities (VIEs).
Key Financial Metrics
| Metric | Six Months Ended Dec 31, 2025 | Six Months Ended Dec 31, 2024 | Change |
|---|---|---|---|
| Revenues | $26,808,565 | $41,537,498 | (35.5%) |
| Gross Profit | $2,362,050 | $614,433 | +284.4% |
| Gross Margin | 8.8% | 1.5% | +7.3 pts |
| Net Loss | $(739,785) | $(3,098,267) | -76.1% (Improvement) |
| Operating Cash Flow | $1,540,994 | $(1,587,572) | Turnaround to Positive |
| Cash & Equivalents (End of Period) | $671,785 | $268,101 | +150.2% |
| Total Debt (Bank Loans) | $3,699,067 | $2,374,767 | +55.8% |
| Working Capital | $(2,017,373) | $(704,978) | Deficit Widened |
Material Changes vs. Prior Period
- Revenue Decline, Margin Expansion: Revenue decreased 35.5% year-over-year due to a strategic contraction of low-margin 5G AI multimodal traffic services. Conversely, Gross Profit increased 284.4% and Gross Margin improved from 1.5% to 8.8%, driven by a shift toward high-margin, solution-oriented offerings and acoustic products.
- Net Loss Reduction: Net loss narrowed significantly by 76.1% to $0.74 million, attributed to the surge in gross profit and a 18.4% reduction in total operating expenses.
- Increased R&D Spend: Research and Development expenses surged 602.1% to $1.25 million, reflecting heavy investment in acoustic medical technologies (Brain-Computer Interface) and industrial precision applications.
- Debt Financing: Bank loan payables increased by $1.32 million (55.8%) to $3.70 million, funded by new credit lines from major Chinese banks (Bank of China, China Construction Bank) to support operations and R&D.
- Intangible Assets Growth: Intangible assets increased 51.6% to $5.30 million due to the acquisition of patents and software copyrights related to AI and acoustic technologies.
Guidance, Outlook, and Risks
- Strategic Outlook: Management views fiscal year 2026 as a period of "execution, validation, and expansion." The focus is shifting from scale expansion to profit quality. The company aims to commercialize acoustic technologies in healthcare (neuromodulation, rehabilitation) and industrial precision manufacturing.
- Going Concern: The filing includes a "Going Concern" warning. Despite improved cash flow, the company has an accumulated deficit of $45.27 million and a working capital deficit. Continued operations depend on the ability to raise additional funds through equity or debt offerings and generate sufficient revenue.
- Internal Control Deficiencies: Management concluded that internal controls over financial reporting were not effective during the period. Deficiencies include insufficient staffing for the internal audit department, lack of timely tracking of control implementation, and a lack of accounting personnel trained in U.S. GAAP.
- Subsequent Events: In January 2026, the company established a subsidiary in the British Virgin Islands (BVI) to relocate its registered office and entered into a new patent purchase agreement for 6G networking technology.
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of the gross margin improvement (8.8%) and whether the decline in revenue volume is a temporary strategic shift or a sign of market contraction.
- Liquidity Runway: Assess the sufficiency of the $671,785 cash balance against the $2.02 million working capital deficit and upcoming debt maturities.
- Related Party Transactions: Review the significant issuance of shares to major shareholders (Zhixin Liu and Fu Liu) for the purchase of intangible assets (software copyrights) and the valuation methodology used.
- Internal Controls: Monitor the remediation plan for the identified material weaknesses in internal controls, specifically regarding U.S. GAAP expertise and internal audit staffing.
- Debt Covenants: Confirm the terms and interest rates of the new bank loans (ranging from 2.30% to 4.95%) and any personal guarantees provided by management.